Management of peripheral facial nerve palsy

Josef Finsterer, Josef Finsterer

Abstract

Peripheral facial nerve palsy (FNP) may (secondary FNP) or may not have a detectable cause (Bell's palsy). Three quarters of peripheral FNP are primary and one quarter secondary. The most prevalent causes of secondary FNP are systemic viral infections, trauma, surgery, diabetes, local infections, tumor, immunological disorders, or drugs. The diagnosis of FNP relies upon the presence of typical symptoms and signs, blood chemical investigations, cerebro-spinal-fluid-investigations, X-ray of the scull and mastoid, cerebral MRI, or nerve conduction studies. Bell's palsy may be diagnosed after exclusion of all secondary causes, but causes of secondary FNP and Bell's palsy may coexist. Treatment of secondary FNP is based on the therapy of the underlying disorder. Treatment of Bell's palsy is controversial due to the lack of large, randomized, controlled, prospective studies. There are indications that steroids or antiviral agents are beneficial but also studies, which show no beneficial effect. Additional measures include eye protection, physiotherapy, acupuncture, botulinum toxin, or possibly surgery. Prognosis of Bell's palsy is fair with complete recovery in about 80% of the cases, 15% experience some kind of permanent nerve damage and 5% remain with severe sequelae.

Figures

Fig. 1
Fig. 1
Right-sided peripheral facial nerve palsy with inability to wrinkle the forehead and nose, unequal lid fissures, and inability to lift the corner of the mouth

References

    1. Kawiak W, Dudkowska A, Adach B. Diagnostic difficulties in etiology of the lesion of peripheral neuron of the facial nerve during the growth of sialoma. Ann Univ Mariae Curie Sklodowska [Med] 1993;48:125–128.
    1. Peitersen E. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 2002;549:4–30.
    1. Shaw M, Nazir F, Bone I. Bell’s palsy: a study of the treatment advice given by neurologists. J Neurol Neurosurg Psychiatry. 2005;76:293–294. doi: 10.1136/jnnp.2004.048439.
    1. Wolf SR. Idiopathic facial paralysis. HNO. 1998;46:786–798. doi: 10.1007/s001060050314.
    1. Axelsson S, Lindberg S, Stjernquist-Desatnik A. Outcome of treatment with valacyclovir and prednisone in patients with Bell’s palsy. Ann Otol Rhinol Laryngol. 2003;112:197–201.
    1. Atzema C, Goldman RD. Should we use steroids to treat children with Bell’s palsy? Can Family Physician. 2006;52:313–314.
    1. Ahmed A. When is facial paralysis Bell palsy? Current diagnosis and treatment. Cleve Clin J Med. 2005;72:398–401.
    1. Slavkin HC. The significance of a human smile: observations on Bell’s palsy. JADA. 1999;130:269–72.
    1. Holland NJ, Weiner GM. Recent developments in Bell’s palsy. Br Med J. 2004;329:553–557. doi: 10.1136/bmj.329.7465.553.
    1. Cole J. About face. Cambridge: MIT Press; 1998.
    1. Mylonas I, Kastner R, Sattler C, Kainer F, Friese K. Idiopathic facial paralysis (Bell’s palsy) in the immediate puerperium in a patient with mild preeclampsia: a case report. Arch Gynecol Obstet. 2005;272:241–243. doi: 10.1007/s00404-005-0742-2.
    1. Zaidi FH, Gregory-Evans K, Acheson JF, Ferguson V. Familial Bell’s palsy in females: a phenotype with a predilection for eyelids and lacrimal gland. Orbit. 2005;24:121–124. doi: 10.1080/01676830490916082.
    1. Devriese PP. Bell’s palsy in children. Acta Otorhinolaryngol Belg. 1984;38:261–267.
    1. de Ru JA, van Benthem PP, Hordijk GJ. Arguments favouring the pharmacotherapy of Bells’ palsy. Ned Tijdschr Geneeskd. 2005;149:1454.
    1. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med. 1996;124:27–30.
    1. Valenca MM, Valenca LP, Lima MC. Idiopathic facial paralysis (Bell’s palsy): a study of 180 patients. Arq Neuropsiquiatr. 2001;59:733–739.
    1. Roob G, Fazekas F, Hartung HP. Peripheral facial palsy: etiology, diagnosis and treatment. Eur Neurol. 1999;41:3–9. doi: 10.1159/000007990.
    1. Marson AG, Salinas R. Bell’s palsy. West J Med. 2000;173:266–268. doi: 10.1136/ewjm.173.4.266.
    1. Prescott CA. Idiopathic facial nerve palsy (the effect of treatment with steroids) J Laryngol Otol. 1988;102:403–407.
    1. Stahl N, Ferit T. Recurrent bilateral peripheral facial palsy. J Laryngol Otol. 1989;103:117–119. doi: 10.1017/S0022215100108199.
    1. Satoh Y, Kanzaki J, Yoshihara S. A comparison and conversion table of ‘the House-Brackmann facial nerve grading system’ and ‘the Yanagihara grading system’. Auris Nasus Larynx. 2000;27:207–212. doi: 10.1016/S0385-8146(99)00049-8.
    1. Ahrens A, Skarada D, Wallace M, Cheung JY, Neely JG. Rapid simultaneous comparison system for subjective grading scales grading scales for facial paralysis. Am J Otol. 1999;20:667–671.
    1. Ross BG, Fradet G, Nedzelski JM. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg. 1996;114:380–386. doi: 10.1016/S0194-5998(96)70206-1.
    1. Ochoa-Sepulveda JJ, Ochoa-Amor JJ. Ondine’s curse during pregnancy. J Neurol Neurosurg Psychiatry. 2005;76:294. doi: 10.1136/jnnp.2004.048025.
    1. Kimura J. Electrodiagnosis of the cranial nerves. Acta Neurol Taiwan. 2006;15:2–12.
    1. Urban PP, Forst T, Lenfers M, Koehler J, Connemann BJ, Beyer J. Incidence of subclinical trigeminal and facial nerve involvement in diabetes mellitus. Electromyogr Clin Neurophysiol. 1999;39:267–272.
    1. Pecket P, Schattner A. Concurrent Bell’s palsy and diabetes mellitus: a diabetic mononeuropathy? J Neurol Neurosurg Psychiatry. 1982;45:652–655.
    1. Stamboulis E, Vassilopoulos D, Kalfakis N. Symptomatic focal mononeuropathies in diabetic patients: increased or not? J Neurol. 2005;252:448–452. doi: 10.1007/s00415-005-0672-8.
    1. Prakash KM, Raymond AA. The use of nerve conduction studies in determining the short-term outcome of Bell’s palsy. Med J Malaysia. 2003;58:69–78.
    1. Ben-David J, Gertner R, Podoshin L, Fradis M, Pratt H, Rabina A. Auditory brain stem evoked potentials in patients suffering from peripheral facial nerve palsy and diabetes mellitus. J Laryngol Otol. 1986;100:629–633. doi: 10.1017/S0022215100099801.
    1. Neau JP, Gil R, Marechaud R, Gouet D, Sudre Y, Lefevre JP. Blink reflex and stimulus detection by the facial nerve in 21 diabetics. Testing before and after precise blood sugar normalization by the artificial pancreas. Acta Neurol Belg. 1985;85:310–317.
    1. Ashtekar CS, Joishy M, Joshi R. Best evidence topic report. Do we need to give steroids in children with Bell’s palsy? Emerg Med J. 2005;22:505–507. doi: 10.1136/emj.2005.026567.
    1. El-Hawrani AS, Eng CY, Ahmed SK, Clarke J, Dhiwakar M. General practitioners’ referral pattern for children with acute facial paralysis. J Laryngol Otol. 2005;119:540–542. doi: 10.1258/0022215054352135.
    1. Furuta Y, Ohtani F, Aizawa H, Fukuda S, Kawabata H, Bergstrom T. Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J. 2005;24:97–101. doi: 10.1097/01.inf.0000151032.16639.9c.
    1. Ogita S, Terada K, Niizuma T, Kosaka Y, Kataoka N. Characteristics of facial nerve palsy during childhood in Japan: frequency of varicella-zoster virus association. Pediatr Int. 2006;48:245–249. doi: 10.1111/j.1442-200X.2006.02197.x.
    1. Tanaka M, Mochizuki M, Sugiyama N, Hamano S. Bell’s palsy in children: analysis of clinical findings and course. No To Hattatsu. 2004;36:461–465.
    1. Nowak DA, Linder S, Topka H. Diagnostic relevance of transcranial magnetic and electric stimulation of the facial nerve in the management of facial palsy. Clin Neurophysiol. 2005;116:2051–2057. doi: 10.1016/j.clinph.2005.05.007.
    1. Turk-Boru U, Kocer A, Bilge C. The efficacy of steroids in idiopathic facial nerve paralysis: an open, randomized, prospective controlled study. Kulak Burun Bogaz Ihtis Derg. 2005;14:62–66.
    1. Beurskens CH, Heymans PG. Positive effects of mime therapy on sequelae of facial paralysis: stiffness, lip mobility, and social and physical aspects of facial disability. Otol Neurotol. 2003;24:677–681. doi: 10.1097/00129492-200307000-00024.
    1. Cederwall E, Olsen MF, Hanner P, Fogdestam I. Evaluation of a physiotherapeutic treatment intervention in “Bell’s” facial palsy. Physiother Theory Pract. 2006;22:43–52. doi: 10.1080/09593980500422529.
    1. Shafshak TF. The treatment of facial palsy from the point of view of physical and rehabilitation medicine. Eura Medicophys. 2006;42:41–47.
    1. Cronin GW, Steenerson RL. The effectiveness of neuromuscular facial retraining combined with electromyography in facial paralysis rehabilitation. Otolaryngol Head Neck Surg. 2003;128:534–538. doi: 10.1016/S0194-5998(03)00005-6.
    1. Liang F, Li Y, Yu S, Li C, Hu L, Zhou D, Yuan X, Li Y. A multicentral randomized control study on clinical acupuncture treatment of Bell’s palsy. J Tradit Chin Med. 2006;26:3–7.
    1. Qu Y. Clinical observation on acupuncture by stages combined with exercise therapy for treatment of Bell palsy at acute stage. Zhongguo Zhen Jiu. 2005;25:545–547.
    1. Li Y, Liang FR, Yu SG, Li CD, Hu LX, Zhou D, Yuan XL, Li Y, Xia XH. Efficacy of acupuncture and moxibustion in treating Bell’s palsy: a multicenter randomized controlled trial in China. Chin Med J (Engl) 2004;117:1502–1506.
    1. Williamson IG, Whelan TR. The clinical problem of Bell’s palsy: is treatment with steroids effective? Br J Gen Pract. 1996;46:743–747.
    1. Micheli R, Telesca C, Gitti F, Giordano L, Perini A. Bell’s palsy: diagnostic and therapeutical trial in childhood. Minerva Pediatr. 1996;48:245–250.
    1. Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, Hayavi S, McAteer A, Stewart K, Daly F. Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med. 2007;357:1598–1607. doi: 10.1056/NEJMoa072006.
    1. Lagalla G, Logullo F, Di Bella P, Provinciali L, Ceravolo MG. Influence of early high-dose steroid treatment on Bell’s palsy evolution. Neurol Sci. 2002;23:107–112. doi: 10.1007/s100720200035.
    1. Tian JF, Li BX, Liu DG, Zhou CY, Wang LL, Han H. Effects of modified SD therapy on Bell’s palsy. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2000;14:551–553.
    1. Lejeune D, Bernat I, Vitte E, Lamas G, Willer JC, Soudant J, Tankere F. Treatment of Bell’s palsy with acyclovir and methylprednisolone. Ann Otolaryngol Chir Cervicofac. 2002;119:209–215.
    1. Chen WL, Yang ZH, Huang ZQ. Outcome of treatment 46 patients with Bell’s palsy with aciclovir and prednisone. Shanghai Kou Qiang Yi Xue. 2005;14:590–592.
    1. Koriyama T, Inafuku S, Kimata K, Banno T, Ishigami H. Recent-onset bell palsy complicated by diabetes: comparison of steroid and lipoprostaglandin E(1) therapy. Arch Otolaryngol Head Neck Surg. 2001;127:1338–1340.
    1. Allen D, Dunn L. Aciclovir or valaciclovir for Bell’s palsy (idiopathic facial paralysis) Cochrane Database Syst Rev. 2004;3:CD001869.
    1. Salinas RA, Alvarez G, Ferreira J. Corticosteroids for Bell’s palsy (idiopathic facial paralysis) Cochrane Database Syst Rev. 2004;4:CD001942.
    1. Hyden D, Roberg M, Forsberg P, Fridell E, Fryden A, Linde A, Odkvist L. Acute “idiopathic” peripheral facial palsy: clinical, serological, and cerebrospinal fluid findings and effects of corticosteroids. Am J Otolaryngol. 1993;14:179–186. doi: 10.1016/0196-0709(93)90027-5.
    1. Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K, Fukuda S, Furuta Y, Ohtani F, Aizawa H, Aoyagi M, Inamura H, Nakashima T, Nakata S, Murakami S, Kiguchi J, Yamano K, Takeda T, Hamada M, Yamakawa K. Valacyclovir and prednisolone treatment for Bell’s palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol. 2007;28:408–413. doi: 10.1097/01.mao.0000265190.29969.12.
    1. Rowlands S, Hooper R, Hughes R, Burney P. The epidemiology and treatment of Bell’s palsy in the UK. Eur J Neurol. 2002;9:63–67. doi: 10.1046/j.1468-1331.2002.00343.x.
    1. Sipe J, Dunn L. Aciclovir for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2001;4:CD001869. Review. Update in: Cochrane Database Syst Rev 2004;3:CD001869
    1. Adour K, Wingerd J, Doty HE. Prevalence of concurrent diabetes mellitus and idiopathic facial paralysis (Bell’s palsy) Diabetes. 1975;24:449–451. doi: 10.2337/diabetes.24.5.449.
    1. Grogan PM, Gronseth GS. Practice parameter: Steroids, acyclovir, and surgery for Bell’s palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:830–836.
    1. Hato N, Matsumoto S, Kisaki H, Takahashi H, Wakisaka H, Honda N, Gyo K, Murakami S, Yanagihara N. Efficacy of early treatment of Bell’s palsy with oral acyclovir and prednisolone. Otol Neurotol. 2003;24:948–951. doi: 10.1097/00129492-200311000-00022.
    1. De Diego JI, Prim MP, De Sarria MJ, Madero R, Gavilan J. Idiopathic facial paralysis: a randomized, prospective, and controlled study using single-dose prednisone versus acyclovir three times daily. Laryngoscope. 1998;108:573–575. doi: 10.1097/00005537-199804000-00020.
    1. Sittel C, Sittel A, Guntinas-Lichius O, Eckel HE, Stennert E. Bell’s palsy: a 10-year experience with antiphlogistic-rheologic infusion therapy. Am J Otol. 2000;21:425–432. doi: 10.1016/S0196-0709(00)80055-1.
    1. Kinishi M, Amatsu M, Hosomi H. Conservative treatment of Bell’s palsy with steroids and dextran-pentoxiphylline combined therapy. Eur Arch Otorhinolaryngol. 1991;248:147–149. doi: 10.1007/BF00178925.
    1. Targan RS, Alon G, Kay SL. Effect of long-term electrical stimulation on motor recovery and improvement of clinical residuals in patients with unresolved facial nerve palsy. Otolaryngol Head Neck Surg. 2000;122:246–252. doi: 10.1016/S0194-5998(00)70248-8.
    1. Yanagihara N, Hato N, Murakami S, Honda N. Transmastoid decompression as a treatment of Bell palsy. Otolaryngol Head Neck Surg. 2001;124:282–286. doi: 10.1067/mhn.2001.112309.
    1. Gantz BJ, Rubinstein JT, Gidley P, Woodworth GG. Surgical management of Bell’s palsy. Laryngoscope. 1999;109:1177–1188. doi: 10.1097/00005537-199908000-00001.
    1. Pausch N, Sterker I, Hemprich A, Frerich B. Restoration of lid function in peripheral facial palsy by implanting gold weights. Mund Kiefer Gesichtschir. 2006;10:135–140. doi: 10.1007/s10006-006-0683-3.
    1. Gidley PW, Gantz BJ, Rubinstein JT. Facial nerve grafts: from cerebellopontine angle and beyond. Am J Otol. 1999;20:781–788.
    1. Sood S, Anthony R, Homer JJ, Van Hille P, Fenwick JD. Hypoglossal-facial nerve anastomosis: assessment of clinical results and patient benefit for facial nerve palsy following acoustic neuroma excision. Clin Otolaryngol Allied Sci. 2000;25:219–226. doi: 10.1046/j.1365-2273.2000.00348.x.
    1. Horlock N, Sanders R, Harrison DH. The SOOF lift: its role in correcting midfacial and lower facial asymmetry in patients with partial facial palsy. Plast Reconstr Surg. 2002;109:839–849. doi: 10.1097/00006534-200203000-00001.
    1. Badarny S, Giladi N, Honigman S. Botulinum toxin injection effective for post-peripheral facial nerve palsy synkinesis. Harefuah. 1998;135:106–107.
    1. Adour KK, Wingerd J. Idiopathic facial paralysis (Bell’s palsy): factors affecting severity and outcome in 446 patients. Neurology. 1974;24:1112–1116.
    1. Unuvar E, Oguz F, Sidal M, Kilic A. Corticosteroid treatment of childhood Bell’s palsy. Pediatr Neurol. 1999;21:814–816. doi: 10.1016/S0887-8994(99)00099-5.
    1. Devriese PP, Schumacher T, Scheide A, de Jongh RH, Houtkooper JM. Incidence, prognosis and recovery of Bell’s palsy. A survey of about 1000 patients (1974–1983) Clin Otolaryngol Allied Sci. 1990;15:15–27. doi: 10.1111/j.1365-2273.1990.tb00427.x.
    1. Kasse CA, Cruz OL, Leonhardt FD, Testa JR, Ferri RG, Viertler EY. The value of prognostic clinical data in Bell’s palsy. Rev Bras Otorrinolaringol (Engl Ed) 2005;71:454–458.
    1. Engstrom M, Jonsson L, Grindlund M, Stalberg E. Electroneurographic facial muscle pattern in Bell’s palsy. Otolaryngol Head Neck Surg. 2000;122:290–297. doi: 10.1016/S0194-5998(00)70258-0.
    1. Rimpilainen I, Eskola H, Laippala P, Laranne J, Karma P. Prognostication of Bell’s palsy using transcranial magnetic stimulation. Acta Otolaryngol Suppl. 1997;529:111–115. doi: 10.3109/00016489709124098.
    1. Kress BP, Griesbeck F, Efinger K, Solbach T, Gottschalk A, Kornhuber AW, Bahren W. Bell’s palsy: what is the prognostic value of measurements of signal intensity increases with contrast enhancement on MRI? Neuroradiology. 2002;44:428–433. doi: 10.1007/s00234-001-0738-y.
    1. Pitts DB, Adour KK, Hilsinger RL., Jr Recurrent Bell’s palsy: analysis of 140 patients. Laryngoscope. 1988;98:535–540. doi: 10.1288/00005537-198805000-00012.
    1. Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology. 1994;44:1198–1202.
    1. Thomke F, Urban PP, Marx JJ, Mika-Gruttner A, Hopf HC. Seventh nerve palsies may be the only clinical sign of small pontine infarctions in diabetic and hypertensive patients. J Neurol. 2002;249:1556–1562. doi: 10.1007/s00415-002-0894-y.
    1. Finsterer J, Auer H (2007) Neurotoxocariasis. Revista do Medical Trop de Sao Paulo (submitted)
    1. Aderibigbe A, Ologe FE. Cervical spinal tuberculosis with tuberculous otitis media masquerading as otitis externa malignans in an elderly diabetic patient: case report. East Afr Med J. 2004;81:267–270.
    1. Zaky DA, Bentley DW, Lowy K, Betts RF, Douglas RG., Jr Malignant external otitis: a severe form of otitis in diabetic patients. Am J Med. 1976;61:298–302. doi: 10.1016/0002-9343(76)90181-9.
    1. Gonzalez Tortosa J, Martinez-Lage JF, Poza M. Bitemporal head crush injuries: clinical and radiological features of a distinctive type of head injury. J Neurosurg. 2004;100:645–651.
    1. Salonen IS, Uusitalo R. Birth injuries: incidence and predisposing factors. Z Kinderchir. 1990;45:133–135.
    1. Ogundipe O, Smith M. Bell’s palsy during interferon therapy for chronic hepatitis C infection in patients with haemorrhagic disorders. Haemophilia. 2000;6:110–112. doi: 10.1046/j.1365-2516.2000.00391.x.
    1. Thai XC, Bruno-Murtha LA. Bell’s palsy associated with linezolid therapy: case report and review of neuropathic adverse events. Pharmacotherapy. 2006;26:1183–1189. doi: 10.1592/phco.26.8.1183.
    1. Ruza Paz-Curbera E, Fernandez Benitez M. Melkersson-Rosenthal syndrome in a diabetic boy. Allergol Immunopathol (Madr) 1998;26:291–293.
    1. Allard P, Kermarec J, Goasguen J, Ferry M, de Muizon H, Girard P, Herning R. Cerebral and pulmonary histiocytosis X. Neurologic manifestations disclosing a pseudotumoral formation on the floor of the 4th ventricle. Rev Pneumol Clin. 1984;40:305–309.
    1. Kamaratos A, Kokkoris S, Protopsaltis J, Agorgianitis D, Koumpoulis H, Lentzas J, Melidonis A, Giannoulis G. Simultaneous bilateral facial palsy in a diabetic patient. Diabetes Care. 2004;27:623–624. doi: 10.2337/diacare.27.2.623.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅